Showing results (2511-2520 of 9,653) with videos related to

Sort By:
Pageof 966
Leukemia|December 25, 2010
HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patientsP Storti, G Donofrio, S Colla, et al.
Leukemia|September 10, 2010
Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM)M Q Lacy, S R Hayman, M A Gertz, et al.
Leukemia|May 29, 2010
IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosisA Tefferi, T L Lasho, O Abdel-Wahab, et al.
Leukemia|May 29, 2010
Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: phase 1 results from the multicenter EVOLUTION studyS K Kumar, I Flinn, S J Noga, et al.
Leukemia|August 21, 2010
Developmentally induced Mll1 loss reveals defects in postnatal haematopoiesisT Gan, C D Jude, K Zaffuto, et al.
Leukemia|January 22, 2011
Targeted next-generation sequencing detects point mutations, insertions, deletions and balanced chromosomal rearrangements as well as identifies novel leukemia-specific fusion genes in a single procedureV Grossmann, A Kohlmann, H-U Klein, et al.
Leukemia|January 23, 2009
Quantification of fusion transcript reveals a subgroup with distinct biological properties and predicts relapse in BCR/ABL-positive ALL: implications for residual disease monitoringM Zaliova, E Fronkova, K Krejcikova, et al.
Leukemia|January 23, 2009
The level of AKT phosphorylation on threonine 308 but not on serine 473 is associated with high-risk cytogenetics and predicts poor overall survival in acute myeloid leukaemiaN Gallay, C Dos Santos, L Cuzin, et al.
Leukemia|February 13, 2009
Caspase activation is involved in early megakaryocyte differentiation but not in platelet production from megakaryocytesY Kozuma, S Yuki, H Ninomiya, et al.
Leukemia|January 17, 2009
The isochromosome i(7)(q10) carrying c.258+2t>c mutation of the SBDS gene does not promote development of myeloid malignancies in patients with Shwachman syndromeA Minelli, E Maserati, E Nicolis, et al.
Pageof 966